Intervention
Microbiome / FMT
- Works
- 19
- Clinical trials
- 2
- Total citations
- 27,795
- Open access
- 16
Evidence brief
previewSynthesis (preview — no live AI key for the active provider):
Across the retrieved literature, senescent-cell burden and chronic inflammation recur as central, interacting drivers, with intervention studies reporting functional gains in model organisms. Key works: [1][2][3][4][5].
Publication velocity
20112026
Clinical trials
Hebrew SeniorLife 2024
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled, Clinical Food Trial of Probiotic/Prebiotic Medical Food for the Dietary Management of Age Related Bone Loss
Stacey Hatch 2020
Open access · US-GOV
Emotion-Focused Mindfulness Therapy: A Feasibility Study for Late Life Anxiety
Most-cited works
Neonatology 2017
Citation only
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
International Journal of Molecular Sciences 2017
Open access · CC-BY
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Signal Transduction and Targeted Therapy 2024
Open access · CC-BY
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Nature Medicine 2019
Preprint · OA
Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice
Aging Cell 2024
Open access · CC-BY
The connection between aging, cellular senescence and gut microbiome alterations: A comprehensive review
Bioscience of Microbiota Food and Health 2020
Open access · CC-BY
Gerobiotics: probiotics targeting fundamental aging processes
Medical Hypotheses 2011
Citation only
Probiotics-induced increase of large intestinal luminal polyamine concentration may promote longevity
Microbiome Research Reports 2024
Open access · CC-BY
Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis
Immunity & Ageing 2024
Open access · CC-BY
Heat-killed probiotic Levilactobacillus brevis MKAK9 and its exopolysaccharide promote longevity by modulating aging hallmarks and enhancing immune responses in Caenorhabditis elegans
Nature communications 2024
Open access · OA